+Susen Rogen

Friday, 6 September 2013

Cameroon Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Creating iOS Games: Beginner Course

Marin Todorov teaches you how to create an iPhone game easily and simply using Cocos2d in this $99 online course.
From our sponsors
Cameroon Pharmaceuticals and Healthcare Report Q4 2013
Sep 4th 2013, 00:00, by rnrmahesh

BMI View: Like several other African countries, low per capita healthcare and pharmaceutical expenditure mean that Cameroon will not be able to attract significant investments from multinational pharmaceutical companies. Weak business environment and poor governance are two key shortcomings, and as a result we maintain that Cameroon must see economic improvements before any success can trickle down to the healthcare sector. Headline Expenditure Projections ? Pharmaceuticals: XAF131.4bn (US$260mn) in 2012 to XAF148.1bn (US$300mn) in 2013; +12.7% in local currency terms and +14.8% in US dollar terms. Forecast broadly in line with Q313. ? Healthcare: XAF701.3bn (US$1.41bn) in 2012 to XAF750.6bn …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113301.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cameroon-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment